Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity
published in: Journal of Hematology & Oncology
date of publication: 2020-11-30
Cites articles
There is nothing here
Article - wd:Q103794703